GYRE THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Gyre Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Gyre Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 93.5M shares, a 146% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 93.5M +55.5M +146% Nov 8, 2024 10-Q 2024-11-13
Q2 2024 93.4M +55.4M +146% Aug 6, 2024 10-Q 2024-08-13
Q1 2024 85.4M +47.7M +126% Mar 19, 2024 10-K 2024-03-27
Q3 2023 38M +6.49M +20.6% Oct 20, 2023 10-Q 2023-10-26
Q2 2023 38M +6.5M +20.6% Aug 4, 2023 10-Q 2023-08-14
Q1 2023 37.8M +6.28M +20% Mar 24, 2023 10-K 2023-03-30
Q3 2022 31.5M +80.3K +0.26% Nov 7, 2022 10-Q 2022-11-14
Q2 2022 31.5M +111K +0.36% Jul 29, 2022 10-Q 2022-08-15
Q1 2022 31.5M +127K +0.41% Mar 31, 2022 10-K/A 2022-05-02
Q3 2021 31.4M +9.31M +42.1% Nov 8, 2021 10-Q 2021-11-12
Q2 2021 31.4M +9.3M +42.2% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 31.3M +13.9M +79.8% Apr 29, 2021 10-Q 2021-05-06
Q3 2020 22.1M +10.1M +83.5% Oct 29, 2020 10-Q 2020-11-05
Q2 2020 22.1M +10M +83.6% Jul 30, 2020 10-Q 2020-08-06
Q1 2020 17.4M +5.47M +45.7% May 1, 2020 10-Q 2020-05-11
Q4 2019 12.1M Feb 7, 2020 10-K 2020-02-20
Q3 2019 12M +98.1K +0.82% Oct 25, 2019 10-Q 2019-11-07
Q2 2019 12M +73.2K +0.61% Jul 26, 2019 10-Q 2019-08-01
Q1 2019 12M +76.4K +0.64% Mar 4, 2019 10-K 2019-03-08
Q3 2018 11.9M +7.63M +177% Oct 29, 2018 10-Q 2018-11-01
Q2 2018 11.9M +7.63M +177% Jul 31, 2018 10-Q 2018-08-02
Q1 2018 11.9M +10.9M +1089% Mar 15, 2018 10-K 2018-03-19
Q3 2017 4.31M -7.72M -64.2% Oct 31, 2017 10-Q 2017-11-02
Q2 2017 4.31M -7.53M -63.6% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 1M -10.4M -91.3% Feb 28, 2017 10-K 2017-03-08
Q3 2016 12M +598K +5.24% Oct 31, 2016 10-Q 2016-11-03
Q2 2016 11.8M -22.5M -65.5% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 11.4M -22.4M -66.3% Apr 29, 2016 10-Q 2016-05-05
Q3 2015 11.4M -22.9M -66.7% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 34.3M +499K +1.48% Jul 27, 2015 10-Q 2015-07-31
Q1 2015 33.9M +87.7K +0.26% Apr 30, 2015 10-Q 2015-05-07
Q3 2014 34.3M +650K +1.93% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 33.8M +157K +0.47% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 33.8M +166K +0.49% Apr 30, 2014 10-Q 2014-05-08
Q3 2013 33.7M +55.2K +0.16% Oct 31, 2013 10-Q 2013-11-06
Q2 2013 33.6M +207K +0.62% Jul 31, 2013 10-Q 2013-08-07
Q1 2013 33.6M +220K +0.66% Apr 30, 2013 10-Q 2013-05-08
Q3 2012 33.6M +223K +0.67% Oct 31, 2012 10-Q 2012-11-08
Q2 2012 33.4M +52.7K +0.16% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 33.4M Apr 30, 2012 10-Q 2012-05-09
Q3 2011 33.4M Oct 31, 2011 10-Q 2011-11-03
Q2 2011 33.4M Jul 31, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.